Intraputamenal cerebral dopamine neurotrophic factor in Parkinson's disease: A randomized, double‐blind, multicenter phase 1 trial
(2023)
Journal Article
Huttunen, H. J., Booms, S., Sjögren, M., Kerstens, V., Johansson, J., Holmnäs, R., …Svenningsson, P. (2023). Intraputamenal cerebral dopamine neurotrophic factor in Parkinson's disease: A randomized, double‐blind, multicenter phase 1 trial. Movement Disorders, 38(7), 1209-1222. https://doi.org/10.1002/mds.29426
Background: Cerebral dopamine neurotrophic factor (CDNF) is an unconventional neurotrophic factor that protects dopamine neurons and improves motor function in animal models of Parkinson's disease (PD). Objective: The primary objectives of this study... Read More about Intraputamenal cerebral dopamine neurotrophic factor in Parkinson's disease: A randomized, double‐blind, multicenter phase 1 trial.